Go beyond small-scale and determine how to build significant digital health influence in the post-pandemic era

It’s time for digital health to mature from opportunistic to deliberate, from local to international, from and tactical to substantiative, strategic propositions. Large pharma firms today need a reliable, well-resourced digital portfolio strategy, whether or not initiatives are standalone or are part of beyond-the-pill initiatives.

How can we develop well-rounded, patient-oriented solutions without losing the agility that digital products expect and require? Much of it can be done at the design phase, where organisational clarity, realistic timelines and funding, robust management, and a successful platform strategy are all within our direct control.

We’ll also focus on how to identify and activate patient populations, gain cross-functional stakeholder alignment, and determine when partnership models are appropriate.

Join us for intense, interactive, hands-on session, followed a great dinner afterwards.